
|Articles|February 6, 2004
AADA urges FDA crackdown of internet-based isotretinoin sales
Schaumburg, Ill. - The American Academy of Dermatology Association (AADA)urged the FDA to stop internet sales of isotretinoin, the active ingredientin Accutane, arguing that such sales pose potential health risks to thepublic. The statement was released at the AAD 2004 annual meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
JAK Inhibitors Show Comparable Safety to TNF Antagonists
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5


















